Back to Journals » Diabetes, Metabolic Syndrome and Obesity » From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM)  and Emerging Diabetes Management Technologies on Metabolic Health

Diabetes, Metabolic Syndrome and Obesity

COPE logo
ISSN: 1178-7007

Journal Sections:

Journal Articles:

From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM)  and Emerging Diabetes Management Technologies on Metabolic Health

Continuous glucose monitoring is widely used in type 1 diabetes to improve management and prevent dangerous fluctuations in blood glucose levels. While CGMs have long been a cornerstone of T1D care, their use is rapidly expanding beyond T1D into Type 2 diabetes and obesity management, offering exciting possibilities for the future of diabetes care. This Article Collection gathers articles that explore the evolving role of CGMs and emerging diabetes management technologies in shaping the future of care for diabetes and obesity, highlighting their ability to improve patient outcomes through personalized, lifestyle-driven, and pharmacology-based interventions.

Identification of Continuous Glucose Monitoring Self-Management Structured Education Programs for People with Type 1 Diabetes Mellitus: A Mixed Methodology Systematic Review

Pizirtzidou E, Karagkounis C, Bellali T, Katsiki N, Kazakos K, Muzurović E, Minasidou E

Diabetes, Metabolic Syndrome and Obesity 2026, 19:598765

Published Date: 12 May 2026